Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Akero, Akston, Alzheon, Avrobio, Brains Bioceutical, Engene, Freeline, Glenmark, IGM, Immunomic, Mymd, Phoenix Molecular, Prota, Rivus, Sangamo, Sanotize, Secura, Silence, Sirnaomics, Sunovion.